Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval | Global News Avenue

Vertex Pharmaceuticals stocks (VRTXOn Friday, the pharmaceutical dealer reported that the federal regulatory agency approved its non -opioid analgesic drug, which was the first drug to be listed in the past 20 years.

The company announced Food and Drug Administration (FDA) Journavx has been approved, which is a pill twice a day. It is described as “a highly selective NAV1.8 pain signal inhibitor for treatment of moderate to severe acute pain”.

CEO Dr. Ryma Kewalramani said that Journavx is “the first type of pain medical category approved for more than 20 years”, and added that the treatment provides “the opportunity to change acute pain management paradigms and establish new nursing standards.”

Speed ​​Acute Pain Guidance Committee member, Dr. Jessica Oswald, said that the approval was “an incredible day for patients and doctors,” he pointed out that Journavx can provide pain and safety of pain to relieve pain. , “There is no potential for addiction.”

Vertex explained that the wholesale purchase price of Journavx, USA is $ 15.50 per 50mg pills.

The news gave Vertex Pharmaceuticals stock, which has only increased by 1 % in the past 12 months, nearly 7 % in the morning.